Pliant Therapeutics Inc (PLRX): Next-Year EPS Estimate 31.26%
As of 2026-07-01, Pliant Therapeutics Inc (PLRX) has a next-year EPS growth estimate of 31.26%.
On 2026-06-30, analyst consensus for PLRX's next-year EPS growth shifted from 25.19% to 31.26% — a positive change of 6.07 percentage points. The revised estimate has been sustained across 2 subsequent trading sessions. Current-year growth is projected at 42.64%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 31.26%
- EPS growth this year
- 42.64%
- EPS next quarter (est)
- -$0.34
- Last price
- $1.12
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-07-01 | 31.26% | 42.64% | -$0.34 | $1.12 |
| 2026-06-30 | 31.26% | 42.64% | -$0.34 | $1.14 |
| 2026-06-29 | 25.19% | 42.05% | -$0.34 | $1.15 |
| 2026-06-28 | 25.19% | 42.05% | -$0.34 | $1.14 |
| 2026-06-25 | 25.19% | 42.05% | -$0.34 | $1.13 |
| 2026-06-24 | 25.19% | 42.05% | -$0.34 | $1.13 |
| 2026-06-23 | 25.19% | 42.05% | -$0.34 | $1.16 |
| 2026-06-22 | 25.19% | 42.05% | -$0.34 | $1.16 |
| 2026-06-21 | 25.19% | 42.05% | -$0.34 | $1.16 |
| 2026-06-18 | 25.19% | 42.05% | -$0.34 | $1.16 |
| 2026-06-17 | 25.19% | 42.05% | -$0.34 | $1.18 |
| 2026-06-16 | 25.19% | 42.05% | -$0.34 | $1.19 |
| 2026-06-15 | 25.19% | 42.05% | -$0.34 | $1.14 |
| 2026-06-14 | 25.19% | 42.05% | -$0.34 | $1.13 |
| 2026-06-11 | 25.19% | 42.05% | -$0.34 | $1.14 |
| 2026-06-10 | 25.19% | 42.05% | -$0.34 | $1.16 |
| 2026-06-09 | 25.19% | 42.05% | -$0.34 | $1.19 |
| 2026-06-08 | 25.19% | 42.05% | -$0.34 | $1.15 |
| 2026-06-07 | 25.19% | 42.05% | -$0.34 | $1.15 |
| 2026-06-04 | 25.19% | 42.05% | -$0.34 | $1.17 |
| 2026-06-03 | 25.19% | 42.05% | -$0.34 | $1.18 |
| 2026-06-02 | 25.19% | 42.05% | -$0.34 | $1.16 |
| 2026-06-01 | 25.19% | 42.05% | -$0.34 | $1.20 |
| 2026-05-31 | 25.19% | 42.05% | -$0.34 | $1.26 |
| 2026-05-28 | 25.19% | 42.05% | -$0.34 | $1.25 |
| 2026-05-27 | 25.19% | 42.05% | -$0.34 | $1.24 |
| 2026-05-26 | 25.19% | 42.05% | -$0.34 | $1.24 |
| 2026-05-25 | 25.19% | 42.05% | -$0.34 | $1.21 |
| 2026-05-24 | 25.19% | 42.05% | -$0.34 | $1.21 |
| 2026-05-21 | 25.19% | 42.05% | -$0.34 | $1.23 |
Screen Performance
Aggregate stats across all 1825 tickers our top-EPS-revision screen has flagged over the past 91 days.
- Median return since detection
- +5.9%
- % of tickers in the green
- 61%
- Median return on winners
- +21.6%
- Large revisions captured
- 920
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Pliant Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-07-01, Pliant Therapeutics Inc (PLRX) has a next-year EPS growth estimate of 31.26%, based on analyst consensus.
When was the latest EPS estimate revision for PLRX?▾
The most recent revision occurred on 2026-06-30, when analysts adjusted the next-year EPS growth estimate from 25.19% to 31.26%.
What sector and industry does Pliant Therapeutics Inc belong to?▾
Pliant Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. PLRX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Pliant Therapeutics Inc (PLRX) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports